Terms: = Leukemia AND MYCL, LMYC, 4610, MYCL1, ENSG00000116990 AND Prognosis
2 results:
1. Overexpression of miR-17 predicts adverse prognosis and disease recurrence for acute myeloid leukemia.
Cao Y; Liu Y; Shang L; Chen H; Yue Y; Dong W; Guo Y; Yang H; Yang X; Liu Y; Gu W; Zhang X
Int J Clin Oncol; 2022 Jul; 27(7):1222-1232. PubMed ID: 35536524
[TBL] [Abstract] [Full Text] [Related]
2. Pathogenesis and therapeutic targeting of aberrant MYC expression in haematological cancers.
Schick M; Habringer S; Nilsson JA; Keller U
Br J Haematol; 2017 Dec; 179(5):724-738. PubMed ID: 29171017
[TBL] [Abstract] [Full Text] [Related]